Molecular determinants of vascular smooth muscle cell diversity
- PMID: 15718508
- DOI: 10.1161/01.RES.0000155951.62152.2e
Molecular determinants of vascular smooth muscle cell diversity
Abstract
Although the primary role of vascular smooth muscle cells (SMCs) is contraction, they exhibit extensive phenotypic diversity and plasticity during normal development, during repair of vascular injury, and in disease states. Results of recent studies indicate that there are unique as well as common transcriptional regulatory mechanisms that control expression of various SMC marker genes in distinct SMC subtypes, and that these mechanisms are complex and dynamic even at the single cell level. This article will review recent progress in our understanding of the transcriptional regulatory mechanisms involved in controlling expression of SMC marker genes with a particular focus on examination of processes that contribute to the phenotypic diversity of SMCs. In addition, because of considerable controversy in the literature regarding the relationship between phenotypically modulated SMCs and myofibroblasts, we will briefly consider both similarities and differences in regulation of gene expression between these cell types.
Similar articles
-
Molecular regulation of vascular smooth muscle cell differentiation in development and disease.Physiol Rev. 2004 Jul;84(3):767-801. doi: 10.1152/physrev.00041.2003. Physiol Rev. 2004. PMID: 15269336 Review.
-
Excitation-transcription coupling in arterial smooth muscle.Circ Res. 2006 Apr 14;98(7):868-78. doi: 10.1161/01.RES.0000216596.73005.3c. Circ Res. 2006. PMID: 16614312 Review.
-
Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression.Circ Res. 2007 Oct 26;101(9):883-92. doi: 10.1161/CIRCRESAHA.107.154831. Epub 2007 Sep 6. Circ Res. 2007. PMID: 17823374
-
Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity.Novartis Found Symp. 2007;283:174-91; discussion 191-3, 238-41. doi: 10.1002/9780470319413.ch14. Novartis Found Symp. 2007. PMID: 18300422 Review.
-
Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli.Arterioscler Thromb Vasc Biol. 2006 May;26(5):1058-65. doi: 10.1161/01.ATV.0000208185.16371.97. Epub 2006 Feb 2. Arterioscler Thromb Vasc Biol. 2006. PMID: 16456091
Cited by
-
TRPML1 channels initiate Ca2+ sparks in vascular smooth muscle cells.Sci Signal. 2020 Jun 23;13(637):eaba1015. doi: 10.1126/scisignal.aba1015. Sci Signal. 2020. PMID: 32576680 Free PMC article.
-
Differentiation of multipotent vascular stem cells contributes to vascular diseases.Nat Commun. 2012 Jun 6;3:875. doi: 10.1038/ncomms1867. Nat Commun. 2012. PMID: 22673902 Free PMC article.
-
Targeting pericytes for angiogenic therapies.Microcirculation. 2014 May;21(4):345-57. doi: 10.1111/micc.12107. Microcirculation. 2014. PMID: 24267154 Free PMC article. Review.
-
Specificity protein-1 as a critical regulator of human cystathionine gamma-lyase in smooth muscle cells.J Biol Chem. 2011 Jul 29;286(30):26450-60. doi: 10.1074/jbc.M111.266643. Epub 2011 Jun 9. J Biol Chem. 2011. PMID: 21659522 Free PMC article.
-
Branched chain α-ketoacids aerobically activate HIF1α signaling in vascular cells.bioRxiv [Preprint]. 2024 May 30:2024.05.29.595538. doi: 10.1101/2024.05.29.595538. bioRxiv. 2024. Update in: Nat Metab. 2024 Nov;6(11):2138-2156. doi: 10.1038/s42255-024-01150-4. PMID: 38853866 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources